🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HPV-Related Cervical Carcinoma

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy NCT07214584n/a1 site📍 Gainesville University of Florida Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women NCT05829629Phase 11 site📍 Bratislava BlueSky Immunotherapies GmbH · Tests: FluBHPVE6E7, Placebo Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study NCT04900623Phase 22 sites📍 Boston📍 Boston Jonathan Schoenfeld, MD, MPH · Tests: NavDx HPV ctDNA Testing, Radiotherapy, Chemotherapy drug Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial NCT07178301Phase 22 sites📍 Chicago📍 Warrenville Northwestern University · Tests: Computed Tomography, Nasopharyngeal Laryngoscopy, Positron Emission Tomography, Questionnaire Administration, Radiation… Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection NCT06052033NA1 site📍 Wenzhou First Affiliated Hospital of Wenzhou Medical University · Tests: CO2 The Minimalist Trial-2 NCT06702033Phase 23 sites📍 St Louis📍 Fargo📍 Sioux Falls Washington University School of Medicine · Tests: Radiation therapy, Cisplatin, Surgery Breast Cancer-Related Approach for Increasing Cervical Cancer Screening NCT07171658NA1 site📍 Geneva Jessica Di Vincenzo Sormani · Tests: Sensitization to Cervical Cancer (CC) screening, Home-based HPV self-sampling Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. NCT03061435NA1 site📍 Toronto Dr. Danielle Vicus · Tests: Screening anal Pap smear - No high-resolution anoscopy, Screening anal Pap smear - High-resolution anoscopy Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer NCT06196190n/a1 site📍 Haifa Rambam Health Care Campus Multimodality Treatments of HPV-related Lesions of the Female Genital Tract NCT05938192n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: vaccination Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation NCT06662058NA1 site📍 Atlanta Emory University · Tests: Audiometric Test, Audiometric Test, Audiometric Test, Interview E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226Phase 23 sites📍 Bethesda📍 New Brunswick📍 New Brunswick Christian Hinrichs · Tests: E7 TCR-T cells, Aldesleukin The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) NCT05419089Phase 22 sites📍 Paramus📍 New York Icahn School of Medicine at Mount Sinai · Tests: Robotic surgery The Women's Screening and Self-Testing Program (PROMETA) Study NCT06810739NA1 site📍 Maputo Tulane University · Tests: HPV DNA testing be self-collected vaginal swab Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier NCT04859530NA1 site📍 Dschang Prof. Patrick Petignat · Tests: AVC test PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer NCT06157151Phase 23 sites📍 Little Rock📍 Bethesda📍 Seattle Precigen, Inc · Tests: PRGN-2009 plus Pembrolizumab Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers NCT05606133NA1 site📍 New York Northwell Health · Tests: NavDx(R) E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972Phase 1, Phase 22 sites📍 New Brunswick📍 New Brunswick Christian Hinrichs · Tests: E7 TCR-T cells, Aldesleukin The Organ Transplant Recipient HPV and Skin Cancer Study NCT05284877n/a3 sites📍 Copenhagen NV📍 Hellerup📍 Roskilde Merete Haedersdal · Tests: No intervention Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca NCT04988074Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Cemiplimab Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial NCT06636734Phase 22 sites📍 Atlanta📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Lovastatin, Magnetic Resonance Imaging, Pembrolizumab Detecting HPV DNA in Anal and Cervical Cancers NCT04857528n/a2 sites📍 Chicago📍 Chicago University of Chicago · Tests: Radiation Treatment With or Without Chemotherapy, Blood Sample Collection, HPV Genotyping (HPV DNA Test), Testing Archi… A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer NCT06319963Phase 1, Phase 24 sites📍 Orlando📍 Tampa📍 Tampa Theravectys S.A. · Tests: Two IM injections Lenti-HPV-07, One IM injection Lenti-HPV-07 Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy NCT05950087n/a1 site📍 Guiyang Guizhou Provincial People's Hospital · Tests: Concurrent chemoradiotherapy Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes NCT06640283Phase 21 site📍 São Paulo Instituto do Cancer do Estado de São Paulo · Tests: ctDNA test, Pembrolizumab SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720Phase 11 site📍 Qingdao The Affiliated Hospital of Qingdao University · Tests: SCG142 TCR-T cells De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA NCT05541016Phase 23 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Diffusing Alpha-emitter Radiation Therapy, Docetaxel Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas NCT06642324n/a1 site📍 Dhaka Bangabandhu Sheikh Mujib Medical University, Dhaka, Banglad… · Tests: Histopathology, Immunohistochemistry, Real-Time PCR, Sequencing A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) NCT05307939Phase 28 sites📍 Miami📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: HPV ctDNA Assay, MRI Studies, EORTC QLQ H&N 35 and C30, MDADI-HN, COST-FACIT Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer NCT07227792NA1 site📍 Pittsburgh Yvonne Mowery · Tests: Tongue-out radiation therapy (TORT)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy